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Drosophila S2 cells and mammalian CHO-K1 cells were used to investigate the requirements for HSV-1
cell fusion. Infection assays indicated S2 cells were not permissive for HSV-1. HVEM and nectin-1
mediated cell fusion between CHO-K1 cells and S2 cells when either CHO-K1 or S2 cells were used as
target cells. Interestingly, PILRa did not mediate fusion between CHO-K1 or S2 cells due to a
glycosylation defect of PILRa and gB in S2 cells. Fusion activity was not detected for any receptor
tested when S2 cells were used both as target cells and effector cells indicating S2 cells may lack a key
cellular factor present in mammalian cells that is required for cell fusion. Thus, insect cells may provide
a novel tool to study the interaction of HSV-1 glycoproteins and cellular factors required for fusion, as
well as a means to identify unknown cellular factors required for HSV replication.
& 2013 Elsevier Inc. All rights reserved.Introduction
Most people encounter herpes simplex virus (HSV) during their
lifetime. HSV infection causes a variety of diseases including recur-
rent mucocutaneous lesions, keratitis, and, in rare cases, meningitis
or encephalitis (Roizman, 1993). HSV utilizes multiple glycoproteins
on the surface of the virion and multiple cell surface receptors to
enter target cells (Connolly et al., 2011). The HSV entry process and
virus-induced cell fusion requires four glycoproteins: B (gB), D (gD),
H (gH) and L (gL). Receptors for gB, gD, and the gH/gL complex have
been identiﬁed. Herpes virus entry mediator (HVEM) (Montgomery
et al., 1996), nectin-1 (Cocchi et al., 1998; Geraghty et al., 1998),
nectin-2 (Lopez et al., 2000; Warner et al., 1998), and modiﬁed
heparan sulfate (Shukla et al., 1999; Shukla and Spear, 2001) all bind
to gD. HVEM is a member of the tumor necrosis factor receptor
family (Ware, 2008). Nectin-1 and nectin-2 are cell adhesion
molecules that belong to the immunoglobulin superfamily and are
widely expressed by a variety of cell types, including epithelial cells
and neurons (Takai et al., 2008). Modiﬁed heparan sulfate generated
by particular 3-O-sulfotransferases can also serve as a gD-binding
entry receptor (Shukla and Spear, 2001). Three gB receptors have
been recently identiﬁed. The paired immunoglobulin-like type 2
receptor alpha (PILRa) (Satoh et al., 2008) is expressed on cells of
the immune system and even in neurons (Fournier et al., 2000; Satoh
et al., 2008; Shiratori et al., 2004). PILRa promotes entry by fusion at
the plasma membrane instead of by acidic endocytosis, as mediatedll rights reserved.
R. Longnecker).by nectin-1 or HVEM when expressed in CHO-K1 cells (Arii et al.,
2009). Myelin-associated glycoprotein (MAG) (Arii et al., 2010) is a
cell-surface molecule that is preferentially expressed in neural tissues
(Liu et al., 2002; McGee et al., 2005; Wang et al., 2002), and non-
muscle myosin heavy chain IIA (NMHC-IIA) (Arii et al., 2010) is
expressed in a wide variety of cultured cells and in vivo (Golomb
et al., 2004; Vicente-Manzanares et al., 2009).
The HSV-1 entry and fusion machinery have been extensively
studied; however, many questions about HSV entry and fusion
remain. For example, it is not clear whether all HSV-1 receptors
have been identiﬁed and of those that have been identiﬁed, which
are the most important. In particular, if multiple HSV glycoprotein
interactions are required for the most efﬁcient entry, cell lines
used for the screening of HSV receptors may already express HSV
receptors that hinder identiﬁcation of the new receptors. In addition,
little is known if the receptors work synergistically or independently.
Finally, different cells and tissues within humans may express
different receptors complicating the determination of which are
the most important for infection and pathogenesis. This type of
difference has become readily apparent in the study of the impor-
tance of HVEM in experimental corneal or vaginal infection of HVEM
knockout mice. In these experiments, HVEM is very important for
infection and pathogenesis in corneal infection, but has little impor-
tance in vaginal infection (Karaba et al., 2011; Taylor et al., 2007). To
develop an experimental means to address these unresolved ques-
tions, we chose to establish a novel system in Drosophila S2 cells,
which are evolutionarily distant from mammalian cells used in
prior experiments. S2 cells have been used for studying Listeria
monocytogenes (Cheng and Portnoy, 2003), Ehrlichia chaffeensis
(Luce-Fedrow et al., 2008), and Chlamydia (Elwell and Engel, 2005).
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characteristics have been used for studying the RNAi response of
West Nile virus (Chotkowski et al., 2008), regulation of viral
transcription and replication of Vesicular stomatitis virus (VZV)
(Blondel et al., 1988), and the discovery of host factors of dengue
virus (Sessions et al., 2009). However, there are no studies using S2
cells to study HSV-1 virus entry and fusion.
In the current studies, we report that S2 cells can be used as a
tool to study HSV cell fusion. We also found that an HSV gD
receptor was all that was required in target cells for the efﬁcient
fusion of the S2 cells with CHO-K1 cells expressing HSV-1
glycoproteins. Interestingly, we found that PILRa and gB
expressed in S2 cells did not function for HSV-1 fusion due to
alterations in glycosylation of gB and PILRa.Results
S2 cells are not susceptible to HSV-1
We ﬁrst tested whether HSV-1 F could replicate in S2 cells
comparably to Vero cells. For these experiments, S2 and Vero cells
were infected for 1 h at 37 1C then washed (upper Fig. 1A) or not
washed with citric acid (lower Fig. 1A). At 24 hpi, infected cell
lysates were collected and analyzed by western blot for the
presence of capsid protein VP5 (Fig. 1A). While VP5 expression
was detected in infected Vero cells, S2 cells failed to express
detectable VP5 after 24 h. To test S2 cells for susceptibility to
HSV-1 entry, we infected S2 cells or Vero cells with a
dual-ﬂuorescent HSV-1 F virus containing a red-ﬂuorescent
capsid (mRFP1-VP26) and a green-ﬂuorescent envelope protein
(GFP-gB). Conceptually, virions that fuse their envelopes with aDIC
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Fig. 1. Infection of Vero cells and S2 cells by HSV-1. (A) VP5 was expressed in infected V
at 37 1C, then treated with citric acid (PH 3.0), the cells were washed 3 times with cold
for 24 h for western. Western blot analysis was performed using a VP5 MAb at 1:500
(B) Virion de-envelopment assay. S2 cells or Vero cells grown on #1.5 coverslips were i
2 h before imaging. Viral particles were assayed for the presence of an envelope by o
represent the standard error of the mean for three independent experiments. **po0
assay. Input virions that have fallen on coverglass demonstrating colalization of the red
shown. Arrowheads indicate capsid locations. Gray values of all green and all red imagtarget cell membrane will lose green ﬂuorescence but retain the
red ﬂuorescent capsid, while virions that do not fuse with a host
cell will be positive for both red capsid and green envelope
ﬂuorescence. Equal numbers of freshly-collected (unfrozen) vir-
ions were added to S2 cells or Vero cells, which were observed at
2 hpi for virion ﬂuorescence composition. We found that 70% of
virions in contact with S2 cells colocalized with a green-
ﬂuorescent envelope, contrasting to only 33% of virions in contact
to Vero cells (Fig. 1B and C). Notably, the 70% envelope-capsid
colocalization in S2 cells was statistically different from the 84%
envelope-capsid colocalization observed in input virions that fell
onto cell-free areas of the coverslip. This was likely caused by
reduced envelope ﬂuorescence detection due to round S2 cells
being present in the light path when compared to a cell-free
imaging area. Monoﬂuorescent (mRFP1-VP26 only) HSV-1 F
colocalized with a nonspeciﬁc green background in S2 cells less
than 5% of the time (data not shown). While capsids could easily
be detected at the nuclear rim of infected Vero cells at 2 hpi, this
localization was never apparent in S2 cells. S2 cells had lower
binding density on average when compared to Vero cells indicat-
ing that HSV-1 virions may not bind as efﬁciently to S2 cells when
compared to Vero cells. However, this reduced binding does not
account for the differences in the proportion of HSV-1 virions
fusing with the target cells as shown in Fig. 1B. Together, these
experiments suggested untransfected S2 cells were neither sus-
ceptible nor permissive for HSV-1 F infection.
Expression of HSV-1 glycoproteins and HSV-1 receptors in S2 cells
HSV-1 gB, gD, gH and gL were cloned into pAc5.1/v5-His A
(Invitrogen) after replacing the native signal sequences with the
BiP signal sequence cloned from pMT/BiP/ V5-His A (Invitrogen).RFP-capsid GFP-gB Merge
ero cells but not S2 cells. Vero cells and S2 cells were infected with HSV-1 F for 1 h
PBSA, incubated in SDM (with 1% serum) or DMEV (DME with 1% serum) medium
0 dilution and a goat anti-mouse HRP-conjugated secondary at a 1:2000 dilution.
nfected with equivalent numbers of ﬂuorescent HSV-1 F virions and incubated for
bserving whether GFP-gB co-localized with a red mRFP1-VP26 capsid. Error bars
.01, ***po0.001. (C–N) Representative micrographs of the virion deenvelopment
and green markers (C–F), infected Vero cells (G–J), and infected S2 cells (K–N) are
es are calibrated equivalently. Length scale bar¼10 um.
Fig. 2. Expression of FLAG-tagged receptors and glycoproteins in S2 cells. (A) Cell surface expression by ﬂow cytometry: S2 cells were transfected in a 6-well plate with
FLAG-PILRa, FLAG-HVEM, FLAG-nectin-1, gB, gD, gH and gL. The transfectants were stained with monoclonal antibody anti-FLAG-M2 (Invitrogen) for FLAG-PILRa, FLAG-
HVEM and FLAG-nectin-1 (F means FLAG-tagged glycoprotein), and rabbit polyclonal antibody R74 for gB, R45 for gD, and R137 for gH/gL. Histograms show ﬂuorescence
intensity measured (x axis) and percentage of expressed cells (y axis). The gray represents cells stained with secondary antibody only. (B) Expression of receptors and
glycoproteins in S2 cells by western blotting. S2 cells were transfected in a 6-well plate with FLAG-tagged PILRa, FLAG-HVEM, FLAG-nectin-1 (F means FLAG-tagged
glycoprotein) and empty vector (upper panel), or gB, gD, gH, gL and empty vector (lower panel). For FLAG-tagged proteins, S2 cells were lysed and were resolved by
SDS-PAGE and transferred to nitrocellulose and probed with rabbit anti-FLAG antibody followed by goat anti-rabbit IgG-HRP. For glycoproteins, S2 cells were lysed and
were resolved by SDS-PAGE and transferred to nitrocellulose and probed with rabbit anti-gB (R74), gD (R45), gH (R87) and gL (R137) antibody followed by goat anti-rabbit
IgG-HRP. All proteins tested migrated at the expected molecular weights.
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Q. Fan et al. / Virology 437 (2013) 100–109 103The native signal sequences for gB (amino acids 1–30), gD (amino
acids 1–25), gH (amino acids 1–18) and gL (amino acids 1–19)
were removed. FLAG-PILRa (Fan and Longnecker, 2010), FLAG-
HVEM (kindly provided by Dr. Carl F. Ware) and FLAG-nectin-1
(Spear lab, originally from Dr. Y. Takai (Osaka University Medical
School, Osaka, Japan) were cloned into pAc5.1/v5-His A, each with
a FLAG peptide located at the N-terminus of the relevant protein.
All plasmids made for this study were sequenced at the North-
western University Genomics core facility.
Flow cytometry was used to verify the cell surface expression
of the FLAG-tagged receptors and glycoproteins in S2 cells. Since
gH requires gL as a chaperone, these two proteins were co-
transfected. For all of the expression constructs, expression of
the proteins of interest was readily detected on the cell surface for
all transfections, while control staining (gray, secondary antibody
only) showed no non-speciﬁc reactivity (Fig. 2A). Expression of
the relevant glycoproteins and receptors was conﬁrmed by
western blotting total cell lysates to conﬁrm expression of each
at the appropriate molecular weight (Fig. 2B).
S2 cells can function as effectors or targets for HSV-induced fusion
Fusion experiments were performed by transfecting target
CHO-K1 or S2 cells with a plasmid encoding luciferase under a
T7 promoter and either empty vector, PILRa (pQF003), HVEMV
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Fig. 3. Cell fusion activity between S2 and CHO-K1 cells mediated by HSV-1 gD and g
HVEM, or nectin-1, along with a reporter plasmid expressing luciferase under control o
transfected with gB, gD, gH and gL, along with plasmids expressing T7 polymerase (A)
(pQF75), along with plasmids expressing T7 polymerase (B). When target S2 cells wer
FLAG-nectin-1, along with a reporter plasmid expressing luciferase under control of
transfected with gB, gD, gH and gL, along with plasmids expressing T7 polymerase (C)
(pQF75), along with plasmids expressing T7 polymerase, fusion results from target CH
(D), Cell fusion activity mediated by each receptor was presented as percentage of nectin
1 (A, B and C) was set as 100% after subtracting the data from the empty vector. E
determinations. v- empty vector.(pBEC10) or nectin-1(pBG38). Alternatively, target S2 cells were
transfected with a plasmid encoding luciferase under a T7
promoter and either empty vector (pAC 5.1v/V5 HisA), FLAG-
PILRa (pQF64), FLAG-HVEM (pQF66) and FLAG-nectin-1(pQF67).
Effector CHO-K1 cells were transfected with a plasmid encoding
T7 RNA polymerase and gB, gD, gH and gL. Effector S2 cells were
transfected with a plasmid encoding T7 RNA polymerase (pQF19)
and gB (pQF72), gD (pQF73), gH (pQF74) and gL (pQF75). Effector
and target cells were mixed and luciferase activity was recorded
as a measure of cell–cell fusion.
The luciferase relative light unit (RLU) intensity varied from
experiment to experiment, and as a result, RLU intensity was
normalized as a percentage of a control for each experiment. The
background RLU intensity of S2 and CHO-K1 cells not expressing a
fusion receptor was usually between 200 and 600, while RLU
intensity of CHO-K1 cells and CHO-K1 cells not expressing a fusion
receptor was between 3590 and 75990, as expected based on our
earlier data, indicating there is a relatively weak endogenous
receptor expressed in CHO-K1 cells (Fan et al., 2009). The lower
RLU intensity between S2 and CHO-K1 cells when no known
receptor expressed may indicate an absence of an endogenous
receptor in S2 cells. When nectin-1 was expressed in S2 or CHO-
K1 cells, the RLU intensity between CHO-K1 cells and S2 cells was
2000–100,000. Nectin-1 mediated fusion between CHO-K1 cells is
usually higher with a RLU intensity around 200,000.v
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B receptors. Target CHO-K1 cells were transfected with pCDNA3 (empty vector),
f the T7 promoter. The transfected cells were replated with effector CHO-K1 cells
, or effector S2 cells transfected with gB (pQF72), gD (pQF73), gH (pQF74) and gL
e transfected with pAc5.1/v5-His A (empty vector), FLAG- PILRa, FLAG-HVEM, or
the T7 promoter. The transfected cells were replated with effector CHO-K1 cells
, or effector S2 cells transfected with gB (pQF72), gD (pQF73), gH (pQF74) and gL
O cells and insect effector cells mediated by nectin-1 was used as positive control
-1 (A, B and C) or percentage of vector background (D). Fusion mediated by nectin-
ach bar shows the mean and standard deviation of at least three independent
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Q. Fan et al. / Virology 437 (2013) 100–109104The background luciferase activity recorded when target cells
were transfected with empty vector was subtracted from each
experiment and for each fusion assay target cells expressing
nectin-1 were set at 100% (Fig. 3A–C). When CHO-K1 cells were
used as target cells and effectors, as expected both the gB receptor
(PILRa) and the gD receptors (HVEM and nectin-1) mediated
robust fusion. Fusion mediated by PILRa was signiﬁcantly lower,
about 20% of the levels mediated by HVEM and nectin-1, agreeing
with our previously reported results (Fan et al., 2012, 2009). Using
combinations of the various receptors did not signiﬁcantly
increase fusion activity (data not shown). When target CHO-K1
cells were added to effector S2 cells, HVEM and nectin-1 could
mediate fusion with HVEM fusion activity approximately 38% of
that of nectin-1 (Fig. 3B). The luciferase activity mediated by
PILRa was usually lower than that of vector control, so the
average value for PILRa was negative. When target S2 cells were
added to effector CHO-K1 cells, fusion mediated by HVEM was
approximately 57% of the level of nectin-1 (Fig. 3C). PILRa did not
mediate fusion when S2 cells were used either as target cells or
effectors cells (Figs. 3B–C), which is different from the CHO-K1
and CHO-K1 fusion observed in Fig. 3A. Again, for S2 and CHO-K1
fusion, using combinations of the various receptors did not
signiﬁcantly increase fusion activity (data not shown). Cell fusion
activity between S2 and S2 cells was not detected by a luciferase
assay (Fig. 3D). For the S2–S2 cell fusion, the background
luciferase activity when target cells were transfected with empty
vector was not subtracted and the activity was set as 100%. Fusion
of target CHO-K1 cells and effector S2 cells was used as a positive
control. Luciferase activity mediated by PILRa, HVEM, or nectin-1
was even lower than that of the vector control for the S2–S2
fusion experiments (Fig. 3D).V
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Fig. 4. Absence of the CHO-K1 endogenous receptor in S2 cells. Target CHO-K1
cells were transfected with pCDNA3 (empty vector) along with a reporter plasmid
expressing luciferase under control of the T7 promoter. The transfected cells were
replated with effector CHO-K1 cells or S2 cells transfected with different
combination of glycoproteins, along with plasmids expressing T7 polymerase.
Target S2 cells were transfected with pAc5.1/v5-His A (empty vector) along with a
reporter plasmid expressing luciferase under control of the T7 promoter. The
transfected cells were replated with effector S2 cells transfected with different
combination of glycoproteins, along with plasmids expressing T7 polymerase. Cell
fusion activity mediated by endogenous receptor was presented as percentage of
vector background (100%). Each bar shows the mean and standard deviation of at
least three independent determinations. v-empty vector.The CHO-K1 endogenous receptor does not function in S2 and
CHO-K1 cell fusion
CHO-K1 cells are resistant to the entry of many viruses like
HSV, PRV, HBV and HIV because receptors for these viruses are
not expressed (Xu et al., 2011) or the CHO-K1 version does not
function. CHO-K1 cells are poor target cells in cell fusion assays
unless transfected to express HSV gB or gD receptors. However,
previous studies indicated that CHO-K1 cells express low levels of
HSV entry/fusion receptors (Fan et al., 2009; Shieh et al., 1992). To
test whether the CHO-K1 endogenous receptors mediate HSV
fusion between CHO-K1 and S2 cells, we performed a cell fusion
assay by transfecting different combinations of glycoproteins into
effector cells. Target CHO-K1 or S2 cells were transfected with
empty vector and a plasmid expressing ﬁreﬂy luciferase gene
under control of the T7 promoter. The background luciferase
activity recorded when target cells were transfected with empty
vector was not subtracted and the activity was set as 100%.
The data are presented as percentage of luciferase activity of
vector control. When effector CHO-K1 cells were transfected with
different combinations of glycoproteins and overlaid with
CHO-K1 cells transfected with T7 luciferase, only the full set of
gB, gD, gH and gL showed fusion activity higher than vector
control (400% of the control) indicating the presence of a weak-Neu   +Neu -Neu  +Neu
Anti-gB
PILRα-Ig
V  gB (CHO-K1) V     gB (S2)
100
100
1 2 3 4 5 6
7 8 9 10 11 12
MW
kDa
1 2 3 4 5 6
100
50
Fig. 5. Mobility of gB and PILRa in S2 cells as well as neuraminidase treatment.
(A) Altered mobility of gB and PILRa in S2 cells when compared to CHO-K1 cells.
S2 cells were transfected in a 6-well plate with gB (pQF72), FLAG-PILRa (pQF64),
and empty vector. CHO-K1 cells were transfected in a 6-well plate with gB
(pPEP98), FLAG-PILRa (pQF22) (Fan and Longnecker, 2010), and empty vector.
Cells transfected with PILRa were lysed and were resolved by SDS-PAGE and
transferred to nitrocellulose and probed with rabbit anti-FLAG antibody followed
by goat anti-rabbit IgG-HRP. Cells transfected with gB were lysed and were
resolved by SDS-PAGE and transferred to nitrocellulose and probed with rabbit
anti-gB (R74) followed by goat anti-rabbit IgG-HRP. (B) Neuraminidase treatment
of gB blocks interaction with PILRa. CHO-K1 cells and S2 cells seeded in six-well
plates were transfected with emptor vector or gB (pPEP98 or pQF72). 24 h later,
cells were treated with neuraminidase (þNeu) or untreated (Neu) for 3 h, lysed,
resolved by SDS-PAGE, transferred to nitrocellulose, and probed with rabbit
polyclonal anti-gB (R74) and PILRa-Ig, respectively, followed by goat anti-rabbit
IgG HRP and anti-human IgG (H&L) (HRP).
Q. Fan et al. / Virology 437 (2013) 100–109 105receptor able to trigger fusion (Fig. 4) similar to our previous
results (Fan et al., 2009). However, when effector cells express
different combinations of glycoproteins in either CHO-K1 cells or
S2 cells, no combination, even the full set of gB, gD, gH and gL
required for fusion, showed higher fusion activity than the vector
control when overlaid with target CHO-K1 or S2 cells (Fig. 4).
These results indicate that S2 cells do not express any functional
fusion receptors for HSV.
The PILRa–gB interaction is blocked due to defects in glycosylation of
gB and PILRa in S2 cells
We next investigated why PILRa did not mediate fusion
between S2 and CHO-K1 despite robust fusion in similar experi-
ments with HVEM and nectin-1. We ﬁrst did western blots of cell
lysates from CHO-K1 cells transfected with gB (pPEP98) or PILRa
(pQF22) (Fan and Longnecker, 2010), or S2 cells with gB (pQF72) or
PILRa (pQF64). Interestingly, gB and PILRa from S2 transfected cells
migrated more rapidly than that from CHO-K1 cells (Fig. 5A). The
difference was more dramatic for PILRa (Fig. 5A, compare lanes 2
and 3 with lanes 5 and 6). Next we employed neuraminidase since
neuraminidase treated gB is not recognized by PILRa-Ig (Wang
et al., 2009). CHO-K1 cells or S2 cells expressing gB were treated
with neuraminidase and lysates from the transfected cells were
probed with anti-gB or PILRa-Ig (Fig. 5B). gB was expressed in both
CHO-K1 and S2 cells and neuraminidase treatment reduced the size
of gB in CHO-K1 cells (Fig. 5B, compare lanes 2 and 3) while
neuraminidase treatment had little effect on gB when expressed in
S2 cells (Fig. 5B, compare lanes 5 and 6). Neuraminidase treatment
of CHO-K1 cells expressing gB abrogated the binding of PILRa-Ig to
gB (Fig. 5B, compare lanes 8 and 9); however, gB was unable to bind
PILRa-Ig when expressed in S2 cells with or without neuraminidase
treatment (Fig. 5B, lanes 11 and 12) indicating PILRa does not bind
gB when expressed in S2 cells. To verify this ﬁnding, we used CHO-
K1 cells or S2 cells expressing gB that had been incubated with
PILRa-Ig, washed, immunoprecipitated with anti-gB, and ﬁnally
probed in western blots with anti-gB (Fig. 6A) or PILRa-Ig (Fig. 6B).
PILRa-Ig immunoprecipitated with only CHO-K1 cells expressing gB
but not S2 cells expressing gB (Fig. 6B, compare lanes 6 and 8),150
100
75
V gB (CHO-K1) V gB (S2)
150
100
75
V gB (CHO-K1) V gB (S2)
Anti-gB
PILRα-Ig
1 2 3 4
5 6 7 8
9 10 11 12
13 14 15 16
MW 
kDa 
IP Monolayer binding assay 
Fig. 6. PILRa-Ig did not bind to gB in S2 cells by immunoprecipitation and
monolayer binding assay. CHO-K1 cells and S2 cells seeded in six-well plates
were transfected with empty vector or gB (pPEP98 or pQF72). 24 h post transfec-
tion, cells were incubated with PILRa-Ig, lysed, and incubated with rabbit anti-gB.
Immune complexes were captured with protein G, and eluted. The eluted proteins
were resolved by SDS-PAGE and transferred to nitrocellulose and probed with
rabbit polyclonal anti-gB (R74) (A) and PILRa-Ig (B), respectively, followed by
goat anti-rabbit IgG HRP and anti-human IgG (H&L) (HRP). For monolayer binding
assay, after 24 h of incubation, cells expressing empty vector and gB in six-well
plates were incubated with PILR-Ig supernatants and washed, and intact cells
were lysed and resolved by SDS-PAGE and transferred to nitrocellulose and probed
with rabbit polyclonal anti-gB (R74) (C) and PILRa-Ig (D), respectively, followed by
goat anti-rabbit IgG HRP and anti-human IgG (H&L) (HRP).indicating PILRa-Ig did not bind to gB on S2 cells, using a monolayer
binding assay which has been previously described (Fan and
Longnecker, 2010). CHO-K1 cells and S2 cells expressing gB were
incubated with PILRa-Ig, and the lysed proteins were separated by
SDS-PAGE and western blot analyses were performed by using the
anti-gB (Fig. 6C) and anti-human IgG HRP (Fig. 6D), the results
showed that PILRa lost binding activity to gB expressed on S2 cells
(Fig. 6D, compare lanes 14 and 16). Taken together, these results
indicate that altered glycosylation of gB (Figs. 5 and 6) or PILRa
(Fig. 5A) occurs in S2 cells resulting in the loss of binding to each
other blocking fusion mediated by PILRa (Fig. 3B–C).Discussion
Herpesviruses engage multiple receptors during viral entry. To
date, four receptors have been identiﬁed for gD (HVEM, nectin-1,
nectin-2, and speciﬁc sites in heparan sulfate generated by certain
isoforms of 3-O-sulfotransferases), and three receptors have
been identiﬁed for gB (PILRa, MAG and NMHC-II). Any of these
cell surface molecules can bind to HSV encoded glycoproteins and
participate in viral entry. Besides an entry receptor, there are also
binding receptors for the HSV. For example, gB can bind to
heparin and heparan sulfate and may contribute, along with gC
(Herold et al., 1991), to the binding of HSV to cell surface heparan
sulfate (Shukla and Spear, 2001). HSV gB and gC can also bind to
DC-SIGN, which serves as a binding receptor for the infection of
dendritic cells (de Jong et al., 2008). gB can bind to cell surfaces
independently of heparan sulfate and can block virus entry
(Bender et al., 2005) indicating there may exist an unidentiﬁed
heparan sulfate-like receptor. Finally, a gH/gL receptor (aVb3
integrin) has been identiﬁed for HSV (Connolly et al., 2011; Parry
et al., 2005). In contrast to gD and gB receptors that seem to
largely function as binding and fusion receptors, the interaction of
integrins with gH/gL appears to dictate the route HSV uses to
enter cells. Speciﬁcally, the interaction of gH/gL and aVb3 route
HSV to an entry pathway dependent on lipid rafts, dynamin 2, and
acidic endosomes (Gianni and Campadelli-Fiume, 2012; Gianni
et al., 2010). Mutated Integrin motifs did not affect virus infection
indicating the role of integrin in gH/gL binding, but not in triggering
fusion (Galdiero et al., 1997). Most experiments investigating HSV
entry have utilized mammalian cells that may express multiple HSV
entry and binding receptors, making it difﬁcult to study the entry
process, and in particular to determine the relative importance of
each for HSV infection. Krummenacher et al. tested the receptor
tropism of HSV clinical isolates and found all were able to use
HVEM as well as nectin-1 in cell culture (Krummenacher et al.,
2004). Interestingly, in our recent studies, we found that
a-herpesviruses herpes B virus and CeHV-2 use nectin-1, but not
HVEM and PILRa, as fusion receptors (Fan et al., 2012).
We directly tested the entry of HSV-1 virus into Vero cells and
S2 cells by infecting these cells with HSV-1 F, leading us to
conclude that S2 cells are not susceptible to the HSV-1 infection
(Fig. 1A–C). To further investigate receptor usage for HSV-1, we
used S2 and CHO-K1 cells for cell fusion assays. From our
experiments, we conclude that HVEM and nectin-1 can function
independently and mediate HSV-1 fusion independently of any
additional identiﬁed receptors (Fig. 3) although we cannot speci-
ﬁcally exclude the possibility that there is S2 factor or factors that
may contribute to fusion mediated by HVEM and nectin-1. In
addition, fusion mediated by the gD receptors HVEM and nectin-1
does not require the gB receptor PILRa, since PILRa did not
mediate fusion between S2 and CHO-K1 cells due to a defect in
glycosylation of gB and PILRa when gB or PILRa was expressed in
S2 cells (Fig. 5). This is in line with previous results demonstrating
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O-glycosylation sites within gB (Wang et al., 2009).
One interesting and somewhat unexpected result from our
current studies is the absence of fusion when S2 cells are used as
effectors and CHO-K1 cells are used as targets when no known
fusion receptors were expressed (Fig. 4). We would have expected
that fusion would occur using the CHO-K1 endogenous receptor,
similar to when CHO-K1 cells are used as both effectors and
targets. The absence of fusion may be due to the absence of an
additional unknown factor that is important for fusion and may
work in cis or trans, since fusion is readily observed when a gD
receptor is expressed in either S2 or CHO-K1 cells and used as
effectors of the opposite cell type. In addition, the absence of fusion
may also be a result of host cell speciﬁc modiﬁcation of HSV-1
glycoproteins such as glycosylation that reduces the functionality
of the glycoprotein resulting in fusion that is not detected in our
current assay because the levels are lower than those observed
when a similar experiment is done with CHO-K1 cells. Future
studies should focus on understanding this observation to deter-
mine if a novel receptor or modiﬁcation exists that might be an
important determinant for fusion. Based on the results when CHO-
K1 cells are used as effectors and S2 cells as targets, we conclude
that S2 cells do not express any functional receptors for HSV-1
fusion. This is compatible with our search of the Drosophila
melanogaster genome for homologous proteins. As might be
expected, the level of identity for NMHC-IIA was the greatest of
any of the HSV entry receptors. Within a region of 1920 amino
acids, there was an identity of approximately 50%. For the other gB
and gD receptors, the level of identity varied from no signiﬁcant
matches for PILRa to limited regions in which identity of between
20% and 30% was observed, but unlikely is functionally signiﬁcant.
This is not surprising since the gB receptor MAG and the gD
receptors nectin-1 and HVEM perform specialized functions in the
more evolutionary complex mammalian systems when compared
to Drosophila melanogaster. Even though we excluded the possibi-
lity of studying roles of gB or the gB receptor PILRa between S2
cells and CHO cells fusion because of a glycosylation defect, the use
of S2 cells for the study of HSV membrane fusion may by an ideal
tool to study the interaction of gD with cellular receptors and may
provide a means to identify novel HSV entry receptors.Materials and methods
Cells and viruses
Chinese hamster ovary (CHO)K1(ATCC) cells, African green
monkey kidney (Vero) cells and Drosophila Schneider 2 (S2) CellsTable 1
Plasmids generated for this study.
Construct Protein Comment
pQF19 T7 polymerase T7 RNA polymerase was cut with SmaI and MscI
of pAC 5.1v/V5 HisA (Invitrogen).
pQF64 FLAG-PILRa pQF22 (PILRa) was cut with XmnI and XbaI and
of pAC 5.1v/V5 HisA.
pQF66 FLAG-HVEM FLAG-HVEM was cut with EcoRI and BamHI and
of pAC 5.1v/V5 HisA.
pQF67 FLAG-nectin-1 FLAG-nectin-1 was cut with XhoI and a fragmen
pQF72 HSV-1 gB The PCR product of the HSV-1 gB ORF (without a
the BiP signal sequence to gB.
pQF73 HSV1-gD The PCR product of the HSV-1 gD ORF (without a
the BiP signal sequence to gD.
pQF74 HSV1-gH The PCR product of the HSV-1 gH ORF (without a
the BiP signal sequence to gH.
pQF75 HSV1-gL The PCR product of the HSV-1 gL ORF (without a
the BiP signal sequence to gL.(Invitrogen) were used in this study. The CHO-K1 cell line and its
derivatives were grown in Ham’s F12 medium supplemented
with 10% fetal bovine serum (FBS). Vero cells were grown and
maintained in DMEM/F-12 phenol red free media supplemented
with 10% FBS. The Drosophila S2 cells were grown in Schneider’s
Drosophila Medium (SDM) (Invitrogen) containing 10% heat inac-
tivated fetal bovine serum (FBS) at 25oC. Fluorescent HSV-1
viruses GS2822 (HSV-1 FþmRFP1-VP26) and GS2843 (HSV-1
FþmRFP1-VP26þGFP-gB), both gifts of Gregory Smith, were
isolated and passaged as described previously (Antinone et al.,
2010).
Plasmids
Plasmids expressing HSV-1(KOS) gB (pPEP98), gD (pPEP99), gH
(pPEP100) and gL (pPEP101) were previously described (Pertel
et al., 2001) as were plasmids expressing human nectin-1, pBG38
(Geraghty et al., 1998), HVEM, pBEC10 (Montgomery et al., 1996)
and PILRa (pQF003) (Fan et al., 2009). New plasmids generated for
this study are shown in Table 1. The insect expression vector,
pAc5.1/v5-His A, was obtained from Invitrogen.
Flow cytometry
Flow cytometry was used to test the cell surface expression of
genes encoding glycoproteins or receptors cloned into pAc5.1/v5-
His A (Invitrogen), an insect vector designed for S2 cells. S2 cells
were seeded in 6-well plates 1 day before and were sub-conﬂuent
when transfected (80–90%). 1 h prior to transfection, the over-
night medium was aspirated and 2 mL of serum-free SDM was
added to each well. 1500 ng of empty vector (pAc5.1/v5-His A), or
plasmid expressing gB (pQF72), gD (pQF73), gH (pQF74)/gL
(pQF75), PILRa (pQF64), HVEM (pQF66), nectin-1 (pQF67) was
diluted in 100 ml serum-free SDM, vortexed brieﬂy and incubated
at room temperature for 20 min. Simultaneously, 8 ml Cellfectin II
(Invitrogen) was diluted in 100 ml serum-free SDM, vortexed
brieﬂy and incubated at room temperature for about 20 min.
The diluted DNA was then combined with the diluted Cellfectin II
and mixed gently and incubated for 10 min before adding the
DNA–lipid mixture drop wise onto the cells. The transfection
medium was aspirated and replaced with SDM 4 h later and
incubated overnight prior to FACS. Cells in each well (about
1 million) were stained with speciﬁc antibodies, rabbit polyclonal
antibody R74 for gB, R45 for gD, R137 for gH/gL (both R45 and
R137 were kindly provided by Dr. Gary H. Cohen and Dr. Roselyn
J. Eisenberg) and the monoclonal antibody anti-FLAG-M2 (Invi-
trogen) for FLAG-tagged PILRa, HVEM and nectin-1. The dataand a fragment containing T7 RNA polymerase was ligated into EcoRV sites
a fragment containing FlAG-PILRa was ligated into EcoRV and XbaI sites
a fragment containing FLAG-HVEM was ligated into EcoRI and BamHI sites
t containing nectin-1 was ligated into XhoI sites of pAC 5.1v/V5 HisA.
mino acid 1–30) from pPEP98 was cloned into pAC 5.1v/V5 HisA after adding
mino acid 1–25) from pPEP99 was cloned into pAC 5.1v/V5 HisA after adding
mino acid 1–18) from pPEP100 was cloned into pAC 5.1v/V5 HisA after adding
mino acid 1–19) from pPEP101 was cloned into pAC 5.1v/V5 HisA after adding
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Control staining was performed with secondary antibodies only.
Western blots
Western blots were performed to monitor expression of HSV-1
glycoproteins and relevant receptors in S2 whole cell lysates. S2
cells seeded in 6-well plates were transfected as described above.
The cells were detached 24 h after transfection using a pipette,
washed with PBS, and lysed with 200 ml of lysis buffer (25 mM
Tris–HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 10 mM NaF, 1 mM
Na3VO3, 1% Nonidet P-40) containing a protease inhibitor mixture
(Roche Diagnostics, Indianapolis, IN). Proteins were separated by
SDS-PAGE on 4–20% gels after boiling for 5 min under reducing
conditions. Western blot analyses were performed using the
rabbit polyclonal antibody R74 for gB at 1:10,000, R45 for gD at
1:10,000, R87 for gH, R137 gL at 1:10,000, and the rabbit anti-
FLAG (Sigma, F7425) at a 1:1000 dilution for proteins of the
FLAG-tagged receptors for 1 h at room temperature. Anti-rabbit
secondary antibody coupled to horseradish peroxidase (HRP) and
ECL
TM
Western blotting detection reagents (GE Healthcare)
were used.
S2 permissivity assay
For detecting VP5 in S2 cells, Vero cells and S2 cells were
seeded in 6-well plates separately 1 day before infection. The
Vero cells and S2 cells were infected with HSV-1 F at MOI 0, 1 and
10, incubated for 1 hour at 37 1C, treated or untreated with citric
acid (PH 3.0) for 1 min, washed 3 times with cold PBSA, incubated
in SDM (with 1% serum) or DMEV (DME with 1% serum) medium
for 24 hours and then lysed for western blotting as described
above. Proteins were separated by SDS-PAGE on 4–20% gels after
boiling for 5 min under reducing conditions. Western blot analy-
sis was performed using VP5 MAb (EastCoast Bio) at 1:5000
dilution and the goat anti-mouse (Santa Cruz) at a 1:2000
dilution.
S2 susceptibility assay
Input virus was puriﬁed on the day of the experiment to
reduce damage to ﬂuorophore ﬂuorescence caused by freezing.
These ﬂuorescent HSV-1 viruses were puriﬁed from Vero cells
infected at a multiplicity of infection (MOI) of 5 plaque forming
units per ml (pfu/ml). During infection, Vero cells were incubated
in phenol red-free F12/DMEM media supplemented with 2%
bovine growth serum. At 48 hpi, supernatants from four 10 cm
culture dishes were collected and cleared of cell debris by
centrifugation at 3000 g for 10 min. Virions were pelleted out of
the cleared supernatant through a 10% Nycodenz cushion (Accu-
rate Chemical, Westbury, NY) at 38500 g for one hour. The
resulting viral pellet was initially resuspended in 100 ml of PBS
and further diluted in phenol-red free media for infection of S2
and Vero cells.
S2 cells or Vero cells grown on #1.5 coverslips cells were
infected with virions puriﬁed as described above with equal
volumes of puriﬁed virus. Infected cells were incubated for 2 h
before imaging. Images were acquired with an inverted wide-ﬁeld
Nikon Eclipse TE2000-U microscope using automated ﬂuores-
cence ﬁlter wheels (Sutter Instruments, Novato, CA), a 601.4
numerical aperture oil objective (Nikon), and a CoolSnap HQ2
camera (Photometrics). The Metamorph software package was
used for image acquisition and processing (Molecular Devices,
Downington, PA). Sequential transmitted light, green, and red
images were acquired at 100 ms, 4 s, and 1 s, respectively.
Micrographs of infected S2 or Vero cells were observed for redparticles (capsids) that were consistent with single point-sources
of ﬂuorescence, and more than 10 pixels away from another
ﬂuorescence point-source. The ‘‘linescan’’ tool was used to
observe histograms of pixel intensities through red and green
images of virons. If there was a green ﬂuorescent local maxima
(4500 grey levels above background) within a ﬁve pixel dia-
meter of a red ﬂuorescent local maxima, the particle was counted
as enveloped. Three independent experiments were performed
and quantiﬁed.
Cell fusion assay
Either CHO-K1 cells or S2 cells were used as effector or target
cells. When CHO-K1 cells were used as effector cells and S2 cells
as target cells, CHO-K1 cells and S2 cells were seeded in 6-well
plates separately 1 day before transfection. The effector CHO-K1
cells were transfected with 400 ng each of plasmids expressing T7
RNA polymerase, gB, gD, gH and gL; and 5 ml of Lipofectamine
2000 (Invitrogen). The target S2 cells overnight medium was
replaced by 2 mL of serum free SDM, transfected with 400 ng of a
plasmid carrying the ﬁreﬂy luciferase gene under control of the T7
promoter, 2.4 mg of empty vector (pAc5.1/v5-His A) or 800 ng of
each plasmid expressing either human PILRa (pQF64), HVEM
(pQF66), nectin-1 (pQF67), and 8 mL of cellfectin II (Invitrogen).
When CHO-K1 cells were used as target and S2 cells as effector,
the target CHO-K1 cells were transfected with 400 ng of a plasmid
carrying the ﬁreﬂy luciferase gene under control of the T7
promoter, 2.4 mg of empty vector (pCDNA3) or 800 ng of each
plasmid expressing either human PILRa (pQF003), HVEM
(pBEC10), nectin-1 (pBG38), and 5 mL of Lipofectamine 2000.
The effector S2 cells were transfected with 400 ng each of
plasmids expressing T7 RNA polymerase (pQF19), gB (pQF72),
gD (pQF73), gH (pQF74), and gL (pQF75); and 8 ml of cellfectin II.
Four h after transfection, the transfection medium in S2 cells were
aspirated and 2 mL of SDM was added to each well. Six h after
transfection, the CHO-K1 cells were detached with versene (0.2 g
EDTA/liter in PBS), and suspended in 1.5 ml of F12 medium
supplemented with 10% FBS. S2 cells in 2 ml SDM were sus-
pended with a pipette. The cells were mixed in a 1:1 ratio and
were replated in 6-well plates with F12 medium and SDM ratio as
1:2. When S2 cells were used as target cells, the mixed S2 and
CHO-K1 cells were incubated at 37 1C for 42 h. When CHO-K1
cells were used as target cells, the mixed CHO-K1 and S2 cells
were incubated at 37 1C for 18 h. For S2 and S2 cells fusion, the
target S2 cells and effector S2 cells were mixed in a 1:1 ratio and
replated into 6-well plates, and the cells were incubated at 25 1C
for 48 h. For S2–CHO-K1 cell fusion and S2–S2 cell fusion, the
medium was aspirated and the cells were lysed with 350 ml lysis
buffer (Promega). In the lysed cells (100 ml) 100 ml of luciferase
substrate was added. The fusion between CHO-K1 cells was done
as described previously (Fan et al., 2009). Luciferase activity was
quantitated by a luciferase reporter assay system (Promega) using
a Wallac-Victor luminometer (Perkin Elmer).
Endogenous receptor cell fusion assay
Target CHO-K1 cells were transfected with 1.5 mg of pCDNA3
(empty vector) along with 400 ng of a plasmid carrying the ﬁreﬂy
luciferase gene under control of the T7 promoter. Target S2 cells
were transfected with only 1.5 mg of pAc5.1/v5-His A (empty
vector) along with a reporter plasmid expressing luciferase under
control of the T7 promoter. The transfected target cells were
replated with effector CHO cells or S2 cells transfected with
400 ng of each the plasmid expressing T7 RNA polymerase, gB
and gD (or pQF72 and pQF73), gD and gH (or pQF73 and pQF74),
gH and gL (or pQF74 and pQF75), gB, gD and gH (or pQF72, pQF73
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and pQF75), along with 400 ng of plasmid expressing T7
polymerase (empty vectors were added to make the total trans-
fection DNA of each treatment to 2.0 mg, if less than this
amount), and 5 ml of Lipofectamine 2000 or 8 ml of Cellfectin II.
Fusion was done as described in Cell fusion assay in Materials and
Methods.PILRa and gB interaction, neuraminidase treatment,
immunoprecipitation, and monolayer binding assay
Neuraminidase treatment was done as previously described
(Teuton and Brandt, 2007; Wang et al., 2009) to test the interac-
tion of PILRa with gB. CHO-K1 cells and S2 cells were seeded in
six-well plates and transfected with 1.5 mg of emptor vector
(pCAGGS or pAC5.1/v5-His A) or gB (pPEP98 or pQF72); 24 h later
transfection, 0.04 U (4 ml) of neuraminidase Arthrobacter ureafa-
ciens (1 U/ml, Roche) was added to the medium and it was
incubated at 37 1C for 3 h. Western blot analyses were performed
on cell lysates by using the rabbit polyclonal anti-gB (R74) at a
1:10,000 dilution and PILRa-Ig at 70 ng/ml respectively, anti-
rabbit secondary antibody coupled to horseradish peroxidase
(HRP) and anti-human IgG (H&L) (HRP) (ab6759; Abcam) at a
1:2000 dilution and ECL
TM
Western blotting detection reagents
(GE Healthcare) were used. Immunoprecipitation and monolayer
binding assay (Fan and Longnecker, 2010) was also used to
investigate the interaction of PILRa (pQF003) with gB expressed
in CHO-K1 and S2 cells. CHO-K1 cells seeded in six-well plates
were transfected with 1.5 mg of empty vector (pCAGGS) or a
plasmid expressing gB (pPEP98). S2 cells seeded in six-well plates
were transfected with 1.5 mg of empty vector (pAC5.1/v5-His A)
or a plasmid expressing gB (pQF72). For immunoprecipitations,
after 24 h of incubation, the cells were washed once with cold
PBS, detached with versene, washed twice with cold PBS and then
incubated with PILRa-Ig (70 ng/ml) for 1 h at room temperature.
The cells were washed 4 times with cold PBS and lysed with
200 ml of lysis buffer (25 mM Tris–HCl [pH 7.4], 150 mM NaCl,
5 mM EDTA, 10 mM NaF, 1 mM Na3VO3, 1% Nonidet P-40) con-
taining a protease inhibitor mixture (Roche Diagnostics, Indiana-
polis, IN), then incubated with R74 for 1 h at 4 1C, washed,
pulled down with protein G (Thermo Scientiﬁc), washed with
cold lysis buffer four times, and eluted the proteins. The eluted
proteins were separated by SDS-PAGE on 4–20% gels after
boiling for 5 min under non-reducing conditions. Western blot
analyses were performed by using the rabbit polyclonal anti-gB
(R74) at a 1:10,000 dilution and PILRa-Ig at 70 ng/ml respectively,
anti-rabbit secondary antibody coupled to horseradish peroxidase
(HRP) and anti-human IgG (H&L) (HRP) (ab6759; Abcam) at a
1:2000 dilution and ECL
TM
Western blotting detection reagents
(GE Healthcare) were used. For monolayer binding assay,
after 24 h of transfection, the cells were washed twice with cold
PBS, incubated with normalized PILR-Ig at about 70 ng/ml
for 1 h at 4 1C, washed with cold PBS four times, and lysed with
200 ul of lysis buffer (25 mM Tris–HCl [pH 7.4], 150 mM NaCl,
5 mM EDTA, 10 mM NaF, 1 mM Na3VO3, 1% Nonidet P-40) con-
taining a protease inhibitor mixture (Roche Diagnostics, Indiana-
polis, IN). Proteins were separated by SDS-PAGE on 4–20% gels
after boiling for 5 min under non-reducing conditions. Western
blot analyses were performed by using the rabbit polyclonal anti-
gB (R74) at a 1:10,000 dilution and anti-human IgG (H&L) (HRP)
(ab6759; Abcam) at a 1:2000 dilution. Anti-rabbit secondary
antibody coupled to horseradish peroxidase (HRP) and anti-
human IgG (H&L) (HRP) (ab6759; Abcam) at a 1:2000 dilution
and ECL
TM
Western blotting detection reagents (GE Healthcare)
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